Sai Parenterals Acquires Majority Stake in Bion Therapeutics
The story in brief
Sai Parenterals Limited has signed a definitive agreement to acquire a majority stake in Bion Therapeutics India Ltd through its subsidiary. The all-cash deal, expected to close by November 2026, will make Bion a step-down subsidiary of Sai Parenterals. Based in Hyderabad, Bion operates in niche therapeutic areas such as neuropathy and diabetes care. The acquisition will expand Sai Parenterals' operations in South, East, and Northeast India, impacting the pharmaceutical market in these regions. The transaction will be funded through internal accruals, debt, and a GCP allocation.